Assessment of long-term renal function after nephrectomy. Study of 53 patients;Estudio de la función renal a largo plazo en 53 pacientes con nefrectomía por diversas causas

Medicina Clinica

Volumn 125, Issue 3, 2005, Pages 81-83

  Galindo Sacristán, Pilar ^a   Osuna Ortega, Antonio ^a   Martínez Sánchez, Teresa ^a   Palomares Bayo, Magdalena ^a   Osorio Moratalla, José Manuel ^a   Asensio Peinado, Concepción ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Microalbuminuria; Nephrectomy; Renal failure progression; Renal function

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; BODY MASS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TUBERCULOSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; OBESITY; PREVALENCE; PROTEINURIA; PYONEPHROSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; STONE FORMATION; UREA NITROGEN BLOOD LEVEL;

EID: 22944490825     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13076738     Document Type: Article

References (22)

1. Fourcade J, Labeeuw M, Demaziere J, Pozet N, Aissa AH. Compensatory hyperfunction in living kidney donors. Nephrologie. 2002;23:173-7.
2. Kasiske BL, Ma JZ, Louis TA, Swan SK. Long-term effects of reduced renal mass in humans. Kidney Int. 1995;48:814.
3. Vlaovic PD, Richardson RM, Miller JA, Donnelly SM, Wright E, Robinette MA. Living donor nephrectomy: follow-up renal function, blood pressure, and urine protein excretion. Can J Urol. 1999;6:901-5.
4. Goldfarb DA. Preservation of renal function and the risk of hyperfiltration nephropathy. Semin Urol Oncol. 1995;13:292-5.
5. Goldfarb DA, Matin SF, Braun WE, Schreiber MJ, Mastroianni B, Papajcik D, et al. Renal outcome 25 years after donor nephrectomy. J Urol. 2001;166:2043-7.
6. Odoni G, Ogata H, Viedt C, Amann K, Ritz E, Orth SR. Cigarette smoke condensate aggravates renal injury in the renal ablation model. Kidney Int. 2002;61:2090-8.
7. Pinto-Sietsma SJ, Mulder J, Janssen WMT, Hillege HL, De Zeeuw D, De Jong PE. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med. 2000;133:585-91.
8. Bakris GL. Microalbuminuria: what is it? Why is it important? What should be done about it? J Clin Hypertension. 2001;3:99-102.
9. Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med. 2001;135:73-87.
10. Jensen JS. Microalbuminuria and the risk of atherosclerosis. Clinical epidemiological and physiological investigations. Dan Med Bull. 2000;47:63-78.
11. Brunskill NJ. Albumin handling by proximal tubular cells: mechanisms and mediators. Nephrol Dial Transplant. 2000;15 Suppl 6:39-40.
12. Remuzzi G. A unifying hypothesis for renal scarring linking protein trafficking to the different mediators of injury. Nephrol Dial Transplant. 2000;15 Suppl 6:58-60.
13. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002;39 Suppl 1:1-266.
14. Coresh J, Eknoyan G, Levey AS. Estimating the prevalence of low glomerular filtration rate requires attention to the creatinine assay calibration. J Am Soc Nephrology. 2002;13:2811-2.
15. Mcclellan WM, Flanders WD. Risk factors for progressive chronic kidney disease. J Am Soc Nephrol. 2003;14:S65-S70.
16. Saran R, Marshall SM, Madsen R, Keavey P, Tapson JS. Long-term follow of kidney donors: a longitudinal study. Nephrol Dial Transplant. 1997;12:1615-21.
17. Praga M, Hernández E, Herrero JC, Morales E, Revilla Y, Díaz-Gonzalez R, et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int. 2000;58:2111-8.
18. Rodríguez Puyol D. The aging kidney. Kidney Int. 1998;54:2247-65.
19. Fuiano G, Sund S, Mazza G, Rosa M, Caglioti A, Gallo G, et al. Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects. Kidney Int. 2001;59:1052-8.
20. Koobi P, Kalliovalkama J, Jolma P, Rysa J, Ruskoaho H, Vuolteenaho O, et al. AT1 receptor blockade improves vasorelaxation in experimental renal failure. Hypertension. 2003;41:1364-71.
21. Praga M. Nefropatía por hiperfiltración. Nefrología. 2000;20:311-35.
22. Hostetter TH. Prevention of the development and progression of renal disease. J Am Soc Nephrol. 2003;14:S144-S7.